Leiomyosarcoma is an aggressive tumor of smooth muscle origin and one of the most common subtypes of sarcoma. The retroperitoneum and uterus are most commonly involved, and less often, the extremities and trunk. A core needle biopsy is typically required for diagnosis. Treatment depends on the size, grade, and location of the lesion, as well as patient-related factors such as age and the ability to tolerate aggressive therapy. Surgery is the cornerstone of curative therapy, with radiation and chemotherapy being important adjuncts. This activity describes the epidemiology, genetics, clinical presentation, and management of leiomyosarcoma, emphasizing the significance of interdisciplinary collaboration in diagnosing and managing leiomyosarcoma to improve patient outcomes. .
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/24180
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.5 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Ambulatory/Outpatient, Complex General Surgical Oncology, Cytopathology, Female Reproductive, General Operative Anesthesia, Hospice & Palliative Medicine, Hospice and Palliative Medicine, Internal Medicine, Medical Oncology, Surgical Pathology